Center for Industrial Base Management and Supply Chain

The COVID-19 pandemic clearly demonstrated the importance of a robust and resilient public health industrial base to national health security.  HHS is expanding the public health industrial base and developing innovative solutions to address critical deficiencies in the public health supply chain by working across the U.S. Government and with academia and the private sector.

ASPR’s Center for Industrial Base Management and Supply Chain (IBMSC) aims to build a diverse, agile public health supply chain and sustain long-term U.S. manufacturing capabilities by investing in medical product Industrial Base Expansion (IBx) capacities that can enable ASPR to respond to future public health emergencies. 

IBMSC coordinates strategic IBx efforts across ASPR, federal partners, academia, and the private sector to operationalize novel solutions and practices for response and recovery operations. IBMSC coordinates the activities related to medical product industrial base expansion and sustainment as described in the following objectives:

• Promote multi-functional capabilities, including advanced manufacturing and supply chain optimization, that ensure relevant stakeholders can access necessary raw materials and components needed for domestic manufacturing.
• Establish innovative domestic industrial base programs and enduring, sustainable partnerships across the medical countermeasure ecosystem including with biotech, pharma, distributors, healthcare, non-profit, and for-profit organizations; and
• Sustain critical medical countermeasures and public health supply advancement and capacity while prioritizing long-term, viable, adaptable domestic industrial base infrastructure to sustain commercial markets, partnerships, and life-cycle supply chain management.
  ​
  


Industrial Base Expansion Portfolio



IBx Connect



Public Health Supply Chain & Industrial Base One-Year Report